1. Baldessarini, R.J. Drugs and the treatment of psychiatric disorders. In: Goodman & Gilmans The Pharmacological Basis of Therapeutics, Hardman, J.G., Limbird, L.E., Molinoff, P.B., Ruddon, R.W., Goodman, A.G., Eds., McGraw-Hill, New York, 1996, pp. 399–430
2. Possible mechanisms by which repeated clozapine administration differentially affects the activity of two subpopulations of midbrain dopamine neurons, J;Chiodo;Neurosci,1985
3. Meltzer, H.Y., Matsubara, S., and Lee, J.C. Classification of typical and atypical antipsychotic drugs on the basis of dopamine D1, D2 and serotonin2 pKi Values., J. Pharm. Exp. Ther. 1989, 251 238–251
4. Schaus, J.M., and Bymaster, F.P. Dopaminergic approaches to antipsychotic agents. In: Annual Reports in Medicinal Chemistry, Robertson, D.W. Ed., Academic Press, New York, 1998, pp. 1–11
5. Minchin, S.A., and Csernansky, J.G. Classification schemes for antipsychotic drugs. In: Antipsychotics Csernansky, J.G. Eds., Springer, Berlin, 1996, pp. 1–21